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until the summer. 
■ RECENT MEETINGS 
At BENHA's October 14 meeting in 
Sacramento, Executive Officer Ray 
Nikkel reported that the Board will begin 
to audit continuing education courses of 
approximately 10% of the state's 2,200 
actively licensed NHAs. 
At BENHA's December meeting, 
Nikkel reported on the annual meeting of 
the Board of Governors of the National 
Association of Boards of Examiners of 
Nursing Home Administrators (NAB), 
which was held on November 3-6 in Co-
lumbus, Ohio. Nikkel reported that NAB 's 
Education Committee approved a com-
mon core curriculum for nursing home 
administrators, which will enable colleges 
and universities interested in offering 
health care administration degrees to work 
with NAB to ensure the most practicable 
courses are offered; and NAB 's Disciplin-
ary Committee is setting up a national 
registry in which all states will report dis-
ciplinary actions taken against NH As. Ac-
cording to Nikkel, California's disciplin-
ary system is being used as the model for 
the national registry. 
■ FUTURE MEETINGS 
To be announced. 
BOARD OF OPTOMETRY 
Executive Officer: Karen Ollinger 
(916) 323-8720 
Pursuant to Business and Professions Code section 3000 et seq., the Board 
of Optometry is responsible for licensing 
qualified optometrists and disciplining 
malfeasant practitioners. The Board estab-
lishes and enforces regulations pertaining 
to the practice of optometry, which are 
codified in Division 15, Title I 6 of the 
California Code of Regulations (CCR). 
The Board's goal is to protect the con-
sumer patient who might be subjected to 
injury resulting from unsatisfactory eye 
care by inept or untrustworthy practition-
ers. The Board consists of nine members, 
including three public members and six 
licensed optometrists. 
■ MAJOR PROJECTS 
License Fee Increase. AB 2566 
(0' Connell) (Chapter 645, Statutes of 
1992) amended Business and Professions 
Code section 3152, authorizing the Board 
to increase its initial application/examina-
tion fee from $75 to a maximum of $275, 
and its annual license renewal fee from 
$85 to a maximum of$150. [12:4 CRLR 
114] The Board desperately needs en-
hanced revenues to fund its licensing and 
enforcement operations, as it has not in-
creased its fees since 1976 and has repeat-
edly been forced to request deficiency 
augmentations because its expenditures 
far exceed its revenues. 
When seeking to increase licensing 
fees, most occupational licensing agen-
cies within the Department of Consumer 
Affairs (DCA) seek legislation establish-
ing a new fee ceiling; they then gradually 
increase fees through the Administrative 
Procedure Act rulemaking process (with 
Office of Administrative Law review for 
necessity) up to that maximum ceiling. 
However, the Board of Optometry be-
lieves it is not required to set its fees 
through rulemaking, and has simply 
raised its application/examination fee to 
$275 and its annual renewal fee to $150, 
effective January I, I 993. 
Board Receives Approval for Addi-
tional Expenditures. The Department of 
Finance recently approved two budget 
change proposals (BCP) to augment the 
Board's enforcement and examination ex-
penditures. 
For the last three fiscal years, the 
Board's budget has fallen short in the en-
forcement area, resulting in deficit spend-
ing (see supra). The budget supplement 
will assist the Board in responding to a 
large increase in the number of complaints 
referred to investigation and referrals to 
the Attorney General's Office. The 
Board's 1992-93 enforcement budget will 
be augmented by $68,028, and by $71,000 
during fiscal year 1993-94. 
The examination BCP covers in-
creased costs for examiners as well as 
exam site rental costs. Expenditure projec-
tions indicated that the Board would not 
have sufficient resources to meet the on-
going demand for subject matter experts, 
expert examiners, and exam site rental. 
The additional allocation of $36,000 dur-
ing 1993-94 is expected to cover actual 
costs. 
DCA Rejects Board's Plan to Abol-
ish Examination Appeal Process. For the 
past year, the Board has been involved in 
a rulemaking proceeding to amend section 
1533 and repeal section I 533.1, Division 
15, Title 16 of the CCR, to abolish its 
examination appeal process. Against op-
position from the California Optometric 
Association, the Board adopted the pro-
posed regulatory changes in February 
1992. [12:4 CRLR 114; 12:2&3 CRLR 
130] However, on December 21, DCA 
Director Jim Conran rejected the proposed 
changes, stating that "elimination of a for-
mal appeal process ... is contrary to the rec-
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ommendations of DCA's Central Testing 
Unit." Conran suggested that the Board 
identify less restrictive alternatives to out-
right abolition of the appeal process, such 
as defined criteria for appeal and time 
restrictions on test use by unsuccessful 
candidates. 
The Board has two options: it may 
attempt to overrule Conran's rejection 
with a unanimous vote, or it may follow 
his suggestion and draft new regulations 
consistent with his comments. 
Board Completes Consumer Educa-
tion Pamphlet. The Board's Public Rela-
tions and Consumer Education Commit-
tee recently completed a consumer educa-
tion pamphlet, which includes an explana-
tion of the relative responsibilities of var-
ious eye care professionals, including op-
tometrists, ophthalmologists, and opti-
cians. The pamphlet also describes how 
optometrists may be disciplined; lists 
twelve types of violations for which an 
optometrist may be disciplined; describes 
the type of information the Board may 
release in response to a consumer inquiry 
about an optometrist; explains the law on 
release of prescriptions for glasses and 
contact lenses; describes how individuals 
may obtain copies of their patient records; 
and explains the process for filing a com-
plaint against an optometrist and the sub-
sequent procedures undertaken by the 
Board. The pamphlet also provides infor-
mation on how to contact the Board of 
Optometry, as well as the major optomet-
ric trade associations and schools. The 
pamphlet will be available to consumers 
as soon as printing is completed. 
Occupational Analysis Study Be-
gins. The Board's long-awaited occupa-
tional analysis of practicing optometrists 
has begun. [12:4 CRLR 113-14] Human 
Resource Strategies is conducting the 
project, which is aimed at identifying in 
great detail how the profession is practic-
ing optometry in the state and developing 
a blueprint for a licensing exam which 
tests for the minimum competence needed 
for an entry-level optometrist. Preliminary 
results of the one-year study are expected 
to be available in October; the final report 
should be completed in December. 
Board Considers Disclosure Regula-
tion Regarding Contact Lens Prescrip-
tions. In an effort to decrease consumer 
confusion, the Board is considering the 
adoption of a regulatory change concern-
ing the release of contact lens prescrip-
tions. [12:4 CRLR 114] At its November 
20-21 meeting, the Board discussed 
adopting proposed section 1566, Title 16 
of the CCR, to require optometrists to post 
a notice containing the following informa-
tion: "Federal Jaw requires that a written 
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copy of the spectacle prescription be given 
to the patient. However, the law does not 
require the release of a contact lens pre-
scription; this is left to the discretion of the 
optometrist. You may want to inquire 
about your doctor's policy regarding the 
contact lens prescription prior to the ex-
amination." A majority of the Board be-
lieves that such a notice requirement is 
necessary to ensure that patients are aware 
of this loophole in the law, noting that its 
Sacramento office has received numerous 
complaints from individuals who were un-
able to obtain a copy of their contact lens 
prescription. Because consumers often as-
sume that they are entitled to receive their 
prescriptions, the Board believes that the 
proposed notice is necessary to inform 
consumers of the law in this area. At this 
writing, the Board has not yet published 
notice of its intent to adopt this regulation 
in the California Regulatory Notice Reg-
ister. 
UCLA Optometry Refresher Course 
Update. The first segment of an optome-
try refresher course primarily designed for 
foreign-trained individuals is now com-
pleted. Forty-one students participated in 
the first part of the course, designed by the 
Board and the University of California 
and offered through the UCLA Health Sci-
ences Extension Program. [ 12:4 CRLR 
114 J Twenty of the students recently com-
pleted the national written basic science 
test (a requirement for licensure); one 
passed and eight others achieved scores 
just below a passing grade. The clinical 
portion of the program began in Septem-
ber and will conclude in April. UCLA 
reported that students are very positive 
about the class, and that the University 
will evaluate the program upon its conclu-
sion. 
■ RECENT MEETINGS 
At its November 20 meeting, the Board 
elected its officers for 1993. Thomas 
Nagy, OD, will continue as president; Jo-
seph Dobbs, OD, will serve as vice-presi-
dent; and John R. Anthony, OD, will serve 
as secretary. 
Executive Officer Karen Ollinger re-
ported on the Board's enforcement statis-
tics for the period of January through June 
1992. During this six-month period, the 
Board received 191 complaints regarding 
optometrists; a total of 643 complaints 
were pending from all prior periods. The 
Board closed a total of 64 complaints; of 
those, 27 resulted in mediated settlements, 
nine were categorized as violations (the 
Board issued two citations with a fine and 
three warning notices), five were referred 
to the Attorney General or other appropri-
ate agency, and 23 were considered un-
actionable. During the six-month period, 
the Attorney General's Office filed three 
accusations against optometrists; all three 
cases resulted in stipulated judgments 
with the optometrist receiving suspension 
and probation. 
The Board also continued its discus-
sion of Business and Professions Code 
section 655, which prohibits landlord-ten-
ant relationships, or any other kind of 
profit-sharing arrangement, between op-
tometrists and opticians. Previously, the 
Board and the Medical Board of 
California's Division of Allied Health 
Professions had disagreed on the proper 
interpretation of section 655. [ 12:4 CRLR 
115 J However, no additional review is 
anticipated at this time, since the Board's 
position is consistent with Attorney 
General's Opinion No. 80-417 (March 4, 
1981 ), and since the Board may establish 
further guidelines for optometrists under 
its direction, if necessary. 
■ FUTURE MEETINGS 
May 20--21 in San Diego. 
BOARD OF PHARMACY 
Executive Officer: Patricia Harris 
(916) 445-5014 
Pursuant to Business and Professions Code section 4000 et seq., the Board 
of Pharmacy grants licenses and permits 
to pharmacists, pharmacies, drug manu-
facturers, wholesalers and sellers of hypo-
dermic needles. It regulates all sales of 
dangerous drugs, controlled substances 
and poisons. The Board is authorized to 
adopt regulations, which are codified in 
Division 17, Title 16 of the California 
Code of Regulations (CCR). To enforce its 
regulations, the Board employs full-time 
inspectors who investigate accusations 
and complaints received by the Board. 
Investigations may be conducted openly 
or covertly as the situation demands. 
The Board conducts fact-finding and 
disciplinary hearings and is authorized by 
law to suspend or revoke licenses or per-
mits for a variety of reasons, including 
professional misconduct and any acts sub-
stantially related to the practice of phar-
macy. 
The Board consists of ten members, 
three of whom are public. The remaining 
members are pharmacists, five of whom 
must be active practitioners. All are ap-
pointed for four-year terms. 
In late December, Governor Wilson 
appointed Darlene Fujimoto to the Board; 
Fujimoto is a senior pharmacist and geri-
atric specialist at the University of Califor-
nia at Irvine Medical Center and consul-
tant pharmacist for Clinical Care Pharma-
cies, Inc. Also in December, Wilson reap-
pointed Janeen McBride to the Board; 
McBride is the western region health care 
specialist for American Drug Stores, Sav-
On Drugs. 
■ MAJOR PROJECTS 
Board to Restructure Enforcement 
Unit. At its October 14-15 meeting, the 
Board discussed its plans to seek a budget 
change proposal (BCP) which would en-
able it to augment its enforcement pro-
gram, which has not been expanded in at 
least ten years. [ 12:4 CRLR 117-18] Ac-
cording to the Board, the expansion is 
necessitated by an increase in the number 
of pharmacies and pharmacists, the estab-
lishment of new registration programs 
such as medical device retailers and phar-
macy technicians, and changes in the law 
governing the practice of pharmacy; fur-
ther, the Board expects that the new man-
datory patient consultation regulations 
which became effective on November I 
will alter the delivery of pharmacy care in 
California, increasing the visibility of the 
profession and the Board's role in protect-
ing the public safety. The Board concedes 
that its failure to expand the enforcement 
program to meet the number of new pro-
grams and licensees has resulted in the 
following problems: 
-Complaints are open too long; conse-
quently, investigation reports are not filed 
in a timely manner, negatively affecting 
public safety. Certain complaints that war-
rant undercover investigation may fail to 
be substantiated simply because the in-
spector cannot devote sufficient time to 
perform a thorough investigation or audit 
due to oppressive workload demands. As 
a result, pharmacists may be cautioned 
with an admonition or scheduled for an 
appearance before one of the Board's In-
terim Disciplinary Committees rather than 
disciplined through the formal adjudica-
tory process. 
-Drug audits are performed only in 
cases where severe shortages are sus-
pected based on the Bureau of Narcotic 
Enforcement reports for Schedule II drugs 
or purchases of excessively large quanti-
ties of certain controlled substances listed 
on the Board's wholesaler distribution re-
port. According to the Board, drug audits 
of Schedule III and IV drugs are even 
more rare, encouraging drug diversion. 
For example, the Board suspects that ste-
roids (Schedule III drugs) are being di-
verted from pharmacies in California for 
illegal sale; because the Board is no longer 
routinely auditing pharmacies' drug in-
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